1Donato F, GelattiU, Limina RM, et al. Southern Europe as an example of interaction between various environmental factors: a systematic reiew of the epidemiologic evidence [ J ]. Oncogene 2006, 25 (27) : 3756 - 3770.
2Marrero JA, Fontana R J, Fu S, et al. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma[J]. Hepatol, 2005,42(2) 218 -224.
4Yoshiyuki Y, Horie Y, Kajihara M, et al. Hepatocellular carcinoma in heavy drinkers with negative markers for viral hepatitis[ J]. Hepatol. 2004,28(4): 177 -183.
5Paradis V, Zalinskis, Chelbi E, et al. Hepatocellular Carcinomas in Patients With Metabolic Syndrome Often Develop Without Significant Liver Fibrosis : A Pathological Analysis [ J ]. Hepatology, 2009, 49 (3):851 -859.
8Lemke LB, Rogers AB, Nambiar PR, et al. Obesity and non - insulin - dependent diabetes mellitus in Swiss - Webster mice associated with late - onset hepatocellular carcinoma [ J ]. Endocrinol, 2008, 199(1):21 -32.
9Chen CL, Yang HI, Yang WS, et al. Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection : A Follow - up Study in Taiwan [ J ]. Gastroenterology, 2008, 135 ( 1 ) : 111 -121.
二级参考文献22
1Bosron W F,Li T K.Genetic Polymorphism of human liver alcohol and aldehyde dehydrogenases,and their relationship to alcohol metabolism and alcoholism[J].Hepatology,1986,6(3):502-510.
2Yamamoto K,Ueno Y,Mizoi Y,et al.Genetic polymorphism of alcohol and aldehyde dehydrogenase and the effects on alcohol metabolism[J].Jpn.J.Alcohol & Drug Dependence,1993,28(1):13-25.
3Groppl A,Begueret J,Iron A.Improved methods for genotype determination of human alcohol dehydrogenase (ADH) at ADH2 and ADH3 loci by using polymerase chain reaction-directed mutagenesis[J].Clinical Chemistry,1990,36(10):1765-1768.
4Woutersen R A,Appelman L M,Van Garderen-Hoetmer A,et al.Inhalation toxicity of acetaldehyde in rats.Ⅲ.Carcinogenicity study[J].Toxicology,1986,41(2):213-231.
5Takeshita T,Morimoto K.Effects of genetic polymorphisms in alcohol-metabolizing enzymes on alcohol hypersensitivity and alcohol-related health problems in orientals[J].Emironmental Health and Preventive Medicine,1996,1(1):65-72.
6Chao Y C,Yong T H,Tang H S,et al.Alcoholism and alcoholic organ damage and genetic polymorphisms of alcohol metabolizing enzymes in Chinese patients[J].Hepatology,1997,25(1):112-118.
7Takeshita T,Yang Y,Inoue Y,et al.Relationship between alcohol drinking,ADH2 and ALDH2 genotypes,and risk for hepatocellular carcinoma in Japanese[J].Cancer Lett,2000,149(1-2):69-76.
8Crabb D W,Edenberg H J,Bosron W F,et al.Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity:the inactive ALDH2*2 allele is dominant[J].J Clin Invest,1989,83(1):314-316.
9Yoshibara E,Ameno K,Nakamura K,et al.The effects of the ALDH2*1/*2,CYP2E1 C1/C2 and C/D genotypes on blood ethnol eliminatio[J].Drug Chem Toxicol,2000,23(2):371-379.
10Mizoi Y,Yamamoto K,Ueno Y,et al.Involvement of genetic polymorphism of alcohol andaldehyde dehydrogenases in individual variation of alcohol metabolism[J].Alcohol,1994,29(6):707-710.
7CHUANG S C,La VECCHIA C’BOFFETTA P. Liver cancer:descriptive epidemiology and risk factors other than HBV andHCV infection[ J]. Cancer Lett,2009,286( 1) :9-14.
8SHARMA S’SALEHI F,SCHEITHAUER B W,et al. Role ofMGMT in tumor development, progression, diagnosis, treatmentand prognosis [J ]. Anticancer Res ,2009,29( 10) :3759-3768.
9Der SIMONIAN R,KACKER R. Random-effects model for me-ta.analysis of clinical trials: an update[ J]. Contemp Clin Tri-als,2007 ,28(2) -.105-114.
10LADEIRO Y.COUCHY G,BALABAUD C,et al. MicroRNAprofiling in hepatocellular tumors is associated with clinicalfeatures and oncogene/tumor suppressor gene Mutations[ J].Hepatology,2008,47(6) : 1955-1963.
